Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism.
about
Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductaseImpaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiencyPharmacogenomics of human P450 oxidoreductasePharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision MedicineNADPH-cytochrome P450 oxidoreductase: prototypic member of the diflavin reductase family.Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation.Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect.Genetic and environmental influences on the ratio of 3'hydroxycotinine to cotinine in plasma and urineInteractions between urinary 4-tert-octylphenol levels and metabolism enzyme gene variants on idiopathic male infertilityIdentification of six novel P450 oxidoreductase missense variants in Ashkenazi and Moroccan Jewish populations.Identification of cytochrome P450 oxidoreductase gene variants that are significantly associated with the interindividual variations in warfarin maintenance dose.A Single Nucleotide Polymorphism in Catalase Is Strongly Associated with Ovarian Cancer SurvivalFunctional POR A503V is associated with the risk of bladder cancer in a Chinese population.Altered human CYP3A4 activity caused by Antley-Bixler syndrome-related variants of NADPH-cytochrome P450 oxidoreductase measured in a robust in vitro systemMultigene predictors of tacrolimus exposure in kidney transplant recipients.Potential biological functions of cytochrome P450 reductase-dependent enzymes in small intestine: novel link to expression of major histocompatibility complex class II genes.Genetic variations in NADPH-CYP450 oxidoreductase in a Czech Slavic cohort.Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factors.Interindividual Variability in Cytochrome P450-Mediated Drug Metabolism.Pharmacogenomics of Cytochrome P450 3A4: Recent Progress Toward the "Missing Heritability" ProblemCorrelation of Cytochrome P450 Oxidoreductase Expression with the Expression of 10 Isoforms of Cytochrome P450 in Human Liver.RNA-sequencing quantification of hepatic ontogeny of phase-I enzymes in mice.Nomenclature for alleles of the cytochrome P450 oxidoreductase gene.Tobacco addiction and pharmacogenetics of nicotine metabolism.An evaluation of regulatory and commercial barriers to stratified medicine development and adoption.Influence of genetic polymorphisms in cytochrome P450 oxidoreductase on the variability in stable warfarin maintenance dose in Han Chinese.Transcriptional Regulation of CYP2D6 Expression.Impact of Drug Treatment at Neonatal Ages on Variability of Drug Metabolism and Drug-drug Interactions in Adult Life.Associations of cytochrome P450 oxidoreductase genetic polymorphisms with smoking cessation in a Chinese population.Mutations of human cytochrome P450 reductase differentially modulate heme oxygenase-1 activity and oligomerization.Impairment of human CYP1A2-mediated xenobiotic metabolism by Antley-Bixler syndrome variants of cytochrome P450 oxidoreductase.Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway.Protein Abundance of Clinically Relevant Drug-Metabolizing Enzymes in the Human Liver and Intestine: A Comparative Analysis in Paired Tissue Specimens.Cytochrome P450 oxidoreductase genetic polymorphisms A503V and rs2868177 do not significantly affect warfarin stable dosage in Han-Chinese patients with mechanical heart valve replacement.Influence of two variants of CYP450 oxidoreductase on the stable dose of acenocoumarol in a Spanish population.In vitro fertilization-frozen embryo transfer in a patient with cytochrome P450 oxidoreductase deficiency: a case report.The P450 oxidoreductase (POR) rs2868177 and cytochrome P450 (CYP) 2B6*6 polymorphisms contribute to the interindividual variability in human CYP2B6 activity.A practice-changing culture method relying on shaking substantially increases mitochondrial energy metabolism and functionality of human liver cell lines.
P2860
Q24607331-286C5464-7E9E-4D5F-9C58-C1A2C24D927EQ24609157-AACB53A3-9BB8-4802-8E4A-EB2480917F4AQ26998463-5CCBCDA8-BD06-4E4C-9F0F-18D4F5636F7DQ27692687-7B0D96A9-B379-466B-A9C3-CC3EA9578C1AQ30537968-F09163B5-3FC6-4F45-A7B4-0EB24FDA19DDQ33431427-52DFC1DF-72B0-4774-881D-863FFF35C07AQ33613333-44ED744C-9A84-41AC-8A10-B6BF588F6CBDQ33768433-CE97A5AE-C9B0-4726-8D09-82EB0921F579Q34649093-ACBB3BA7-161D-4A10-A7D4-C79FD131E449Q34731517-55439639-8E21-4658-8152-B3CA9D7A1271Q35122798-EED6B995-C870-4CA6-B0DA-54D5772C61FAQ35753523-1E08BD98-F2E2-493A-A12C-978E79D9A2DCQ35796654-E28DED37-3299-4071-8037-BE70553DF4D4Q35846903-20B410C0-F787-4B4E-9DCA-D6C382A626FBQ35924246-250115CB-CC99-43BB-9075-79D6FA9E0DA1Q36007003-7F115683-5746-474D-AB21-3E60B8F580F6Q36326565-3A6A9D72-923D-428D-9260-4682C65F6832Q36459910-C5D5BF0F-EF02-4205-808C-DE6A36557186Q36618692-0DD1A223-73EF-4821-BF35-25B49BBBA007Q36634077-6969FA6D-3C8C-4DB3-A76C-4E6564E33695Q37179263-193361B6-01CD-48F3-8C7A-7B441095CFC9Q37325574-92C4A7EA-1477-43BF-B906-752FA99230FEQ37365498-90B78731-73D5-4D00-B22F-29E89D2516E7Q37371779-355433C1-C651-44DD-94BD-59C8E1529752Q38257149-2A111B28-D12F-46B1-8258-ABEDA7F5A91CQ38834803-75DE140E-CB71-491B-917D-C62C6DBB7416Q38971321-B273CDC2-1FD7-42A8-BBAD-3AA284A9DFEBQ39201730-1E85FBCF-E270-43EF-8ECC-DD888B97B63EQ40569108-56A23275-A392-4538-B864-A15EB151AFBDQ41892436-9666E245-A610-4025-A87C-9B3E36926111Q43069462-0D85CD0C-3E76-4F13-88DD-7BAC65172344Q47116870-6FD46ADD-75A8-4956-BBF9-D4101A1411B6Q47330563-E7FED19F-A5F8-4162-BD50-976E384FA91FQ47770395-BF935AF0-1748-4C36-8B5C-AE92FB867ED9Q47812050-C6905669-1577-478E-B65F-FD6120D49E13Q50083476-EF1E0230-0043-40F5-B4AA-DB8694EDB6EBQ51628497-92AA7221-6F68-43D6-9D97-5553FB0425A4Q55249382-F2DBC2DC-7E43-4D83-BA2E-822F7A8F8317
P2860
Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Genetic polymorphisms in cytoc ...... 450-catalyzed drug metabolism.
@ast
Genetic polymorphisms in cytoc ...... 450-catalyzed drug metabolism.
@en
Genetic polymorphisms in cytoc ...... 450-catalyzed drug metabolism.
@nl
type
label
Genetic polymorphisms in cytoc ...... 450-catalyzed drug metabolism.
@ast
Genetic polymorphisms in cytoc ...... 450-catalyzed drug metabolism.
@en
Genetic polymorphisms in cytoc ...... 450-catalyzed drug metabolism.
@nl
prefLabel
Genetic polymorphisms in cytoc ...... 450-catalyzed drug metabolism.
@ast
Genetic polymorphisms in cytoc ...... 450-catalyzed drug metabolism.
@en
Genetic polymorphisms in cytoc ...... 450-catalyzed drug metabolism.
@nl
P2093
P1476
Genetic polymorphisms in cytoc ...... P450-catalyzed drug metabolism
@en
P2093
Christopher Wesselman
Kaori Nakamoto
Shuang Wang
Xiao-bo Zhong
P356
10.1097/FPC.0B013E3282F2F121
P577
2008-01-01T00:00:00Z